Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial

K.M.L. Huijbregts, N.M. Batelaan, J. Schonenberg, G. Veen, A.J.L.M. van Balkom

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)336-338
JournalJournal of Clinical Psychopharmacology
Volume35
Issue number3
DOIs
Publication statusPublished - 2015

Cite this